Using a Low Dose of Ketamine vs. Active Placebo in Treating Severe Depression and Suicide

Summary

Depression and suicide are two leading mental health and public health issues in Taiwan. However, until now, the optimal treatment for refractory depression and suicide is still lacking. Previous USA studies suggested a low dose NMDA antagonist Ketamine infusion can significantly reduce depression and suicide. In our study, we firstly investigate the anti-suicide and anti-depressive effects of ketamine in Taiwan. If we can find the similar antidepressant and anti-suicide of ketamine in Taiwanese, this result will have a great influence in the current suicide and depression prevention programs.

Timeline

Start

2018-09-10

Primary completion

2021-12-31

Completion

2021-12-31

Drugs

Indications